Skip to main content

Advertisement

Log in

Letter to the Editor: Intrapancreatic Accessory Spleen Masquerading as a Pancreatic Neuroendocrine Tumor

  • Letter to the Editor
  • Published:
Journal of Gastrointestinal Surgery

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Vikse J, Sanna B, Henry BM, et al. The prevalence and morphometry of an accessory spleen: A meta-analysis and systematic review of 22,487 patients. Int J Surg. 2017;45:18–28.

    Article  PubMed  Google Scholar 

  2. Bhutiani N, Egger ME, Doughtie CA, et al. Intrapancreatic accessory spleen (IPAS): A single-institution experience and review of the literature. Am J Surg. 2017;213:816–820.

    Article  PubMed  Google Scholar 

  3. Se HK, Jeong ML, Joon KH, et al. Intrapancreatic accessory spleen: Findings on MR imaging, CT, US and scintigraphy, and the pathologic analysis. Korean J Radiol. 2008;9:162–174.

    Article  Google Scholar 

  4. Kawamoto S, Johnson PT, Hall H, et al. Intrapancreatic accessory spleen: CT appearance and differential diagnosis. Abdom Imaging. 2012;37:812–827.

    Article  PubMed  Google Scholar 

  5. Li BQ, Xu XQ, Guo JC. Intrapancreatic accessory spleen: a diagnostic dilemma. HPB. 2018;20:1004–1011.

    Article  PubMed  Google Scholar 

  6. Lu M, Cohen MH, Rieves D, et al. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol. 2010;85:315–319.

    CAS  PubMed  Google Scholar 

  7. Toth GB, Varallyay CG, Horvath A, et al. Current and Potential Imaging Applications of Ferumoxytol for Magnetic Resonance Imaging. Kidney Int. 2017;92:47–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Vasanawala SS, Nguyen K, Hope MD, et al. Safety and technique of ferumoxytol administration for MRI. Magn Reson Med. 2016;75:2107–2111.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Knobloch G, Colgan T, Wiens CN, et al. Relaxivity of Ferumoxytol at 1.5 T and 3.0 T. Invest Radiol. 2018;53:257–263.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bashir MR, Bhatti L, Marin D, et al. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging. 2015;41:884–898.

    Article  PubMed  Google Scholar 

  11. Spencer LA, Spizarny DL, Williams TR. Imaging features of intrapancreatic accessory spleen. Br J Radiol. 2010;83:668–673.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Scott B. Reeder, MD, PHD is funded by the NIH under award numbers K24 DK102595 and R01 DK100651. Victoria Rendell, MD is funded by the NIH under award number F32 CA232352.

Author information

Authors and Affiliations

Authors

Contributions

ERW and SBR conceived of this letter to the editor. VRR composed the letter and, along with MRM, acquired and synthesized contributing references and prepared the figure. All authors revised the manuscript and gave final approval of the version to be published.

Corresponding author

Correspondence to Victoria R. Rendell.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rendell, V.R., Mühler, M.R., Winslow, E.R. et al. Letter to the Editor: Intrapancreatic Accessory Spleen Masquerading as a Pancreatic Neuroendocrine Tumor. J Gastrointest Surg 23, 1717–1718 (2019). https://doi.org/10.1007/s11605-019-04110-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-019-04110-6

Navigation